The world is now a smaller place, where international travel is feasible and accessible to a large population. Traveler’s diarrhea (TD) is a clinical syndrome of diarrhea, abdominal pain, fever, vomiting, and bloody diarrhea within 2 weeks of travel. The CDC estimates that TD affects 30–70% of travelers. There are several categories of traveler’s diarrhea: mild, moderate, severe, and persistent. The highest-risk areas for TD are Asia, the Middle East, Africa, Mexico, Central America, and South America. Bacterial pathogens are responsible for 80–90% of TD cases.
KeywordsTraveler’s diarrhea Loperamide Diarrhea Dehydration Abdominal pain Antibiotics
- 1.Connor B. Travelers’ health [document on internet]. 2017 June 13 [cited 2018 January 16]. Available from https://wwwnc.cdc.gov/travel/yellowbook/2018/the-pre-travel-consultation/travelers-diarrhea.
- 5.Riddle MS, Connor P, Fraser J, Porter CK, Swierczewski B, Hutley EJ, et al. Trial evaluating ambulatory therapy of travelers’ diarrhea (TrEAT TD) study: a randomized controlled trial comparing 3 single-dose antibiotic regimens with loperamide. Clin Infect Dis. 2017;65(12):2008–17.CrossRefGoogle Scholar
- 8.Connor B. Travelers’ Health. 2017. Retrieved January 16, 2018, from https://wwwnc.cdc.gov/travel/yellowbook/2018/the-pre-travel-consultation/travelers-diarrhea.
- 9.Riddle MS, Connor BA, Beeching NJ, DuPont HL, Hamer DH, Kozarsky P, Libman M, Steffen R, Taylor D, Tribble DR, Vila J, Zanger P, Charles D. Ericsson; Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report. J Travel Med. 2017;24(suppl_1):S63–80. https://doi-org.proxy.library.georgetown.edu/10.1093/jtm/tax026CrossRefGoogle Scholar